IV ProvayBlue vs compounded oral vs aquarium liquid
Every row cites its source. Where a cell reflects our own reading of the evidence rather than an external source, the row says so.
| Dimension | Provayblue Iv | Compounded Oral | Aquarium | Source |
|---|---|---|---|---|
| Regulatory status | FDA-approved drug (NDA 204630) | Not FDA-approved; pharmacy-compounded on prescription, outside FDA review of safety and effectiveness | Not a drug at all | source |
| Quality control | USP injection monograph; labeled impurity control (azure B) | USP-grade source material achievable through licensed pharmacies (as in the Rodriguez trial) | No drug-grade specification | source |
| Evidence attached to the form | Label clinical studies: 92.9% methemoglobin response; shock-state RCT evidence | Single-dose imaging trial and small augmentation trials | None | source |
| Where risk information lives | Boxed warning, contraindications, overdose bands, all on a public label | Same molecule, same risks, but no label in the buyer's hands | No human-use risk information exists | source |
Same molecule, three completely different accountability chains.